Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00045773 · ClinicalTrials.gov registry record
Treatment Outcome of Vascular Depression
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 208
- Enrollment target
NCT00045773: Completed study, sponsored by University of Pennsylvania.
NCT00045773 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 208 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00045773 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 208 participants
- Enrollment target
Study Summary
This 12-week study will evaluate the effectiveness of sertraline (Zoloft®) for treatment of depression associated with small vascular lesions in the brain (vascular depression).
Interventions
- DRUG Sertraline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 208 participants |
| Start Date | 2001-04 |
| Est. Completion | 2006-04 |
What the finished NCT00045773 record still lists
NCT00045773 is an observational study that tracks outcomes without assigning an intervention. The registered 208 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Sertraline is the first listed.
NCT00045773 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00045773 about?
NCT00045773 is a clinical study titled "Treatment Outcome of Vascular Depression". This 12-week study will evaluate the effectiveness of sertraline (Zoloft®) for treatment of depression associated with small vascular lesions in the brain (vascular depression).
What is the current status of trial NCT00045773?
This trial is currently completed. The enrollment target is 208 participants. The study started on 2001-04. Estimated completion is 2006-04.
What interventions are being tested in trial NCT00045773?
The interventions under investigation include: Sertraline (DRUG).
Who is sponsoring clinical trial NCT00045773?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465774 · 208 participants
Indwelling Pleural Catheters With or Without Doxycycline in Treating Patients With Malignant Pleural Effusions
- NCT03803332 · 208 participants · NA
A Trial Comparing Interpersonal Therapy to Exposure Therapy for PTSD Due to Military Sexual Trauma (MST) in Male and Female Military Personnel
- NCT04732065 · 208 participants · Phase 1
ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
- NCT05293756 · 208 participants · NA
OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia